nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP1B1—Tamoxifen—pancreatic cancer	0.0614	0.0874	CbGbCtD
Omeprazole—ABCC3—Fluorouracil—pancreatic cancer	0.0523	0.0745	CbGbCtD
Omeprazole—CYP1B1—Erlotinib—pancreatic cancer	0.0522	0.0743	CbGbCtD
Omeprazole—CYP1B1—Docetaxel—pancreatic cancer	0.0345	0.0492	CbGbCtD
Omeprazole—CYP1A1—Dacarbazine—pancreatic cancer	0.0339	0.0482	CbGbCtD
Omeprazole—ABCC3—Doxorubicin—pancreatic cancer	0.0298	0.0424	CbGbCtD
Omeprazole—ABCG2—Tamoxifen—pancreatic cancer	0.0292	0.0415	CbGbCtD
Omeprazole—ATP4A—gastric juice—pancreatic cancer	0.027	0.53	CbGeAlD
Omeprazole—CYP1A1—Tamoxifen—pancreatic cancer	0.0269	0.0383	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—pancreatic cancer	0.0257	0.0366	CbGbCtD
Omeprazole—ABCG2—Erlotinib—pancreatic cancer	0.0248	0.0353	CbGbCtD
Omeprazole—CYP1A1—Erlotinib—pancreatic cancer	0.0229	0.0326	CbGbCtD
Omeprazole—ABCG2—Irinotecan—pancreatic cancer	0.0224	0.0319	CbGbCtD
Omeprazole—ABCG2—Fluorouracil—pancreatic cancer	0.0215	0.0306	CbGbCtD
Omeprazole—ABCG2—Docetaxel—pancreatic cancer	0.0164	0.0234	CbGbCtD
Omeprazole—ABCG2—Sunitinib—pancreatic cancer	0.0163	0.0233	CbGbCtD
Omeprazole—CYP2C8—Tamoxifen—pancreatic cancer	0.0155	0.0221	CbGbCtD
Omeprazole—CYP1A2—Dacarbazine—pancreatic cancer	0.0151	0.0215	CbGbCtD
Omeprazole—CYP2C8—Erlotinib—pancreatic cancer	0.0132	0.0188	CbGbCtD
Omeprazole—CYP2C19—Tamoxifen—pancreatic cancer	0.013	0.0186	CbGbCtD
Omeprazole—ABCG2—Doxorubicin—pancreatic cancer	0.0122	0.0174	CbGbCtD
Omeprazole—CYP1A2—Tamoxifen—pancreatic cancer	0.012	0.0171	CbGbCtD
Omeprazole—CYP2C8—Fluorouracil—pancreatic cancer	0.0115	0.0163	CbGbCtD
Omeprazole—CYP2C9—Tamoxifen—pancreatic cancer	0.0108	0.0154	CbGbCtD
Omeprazole—ABCB1—Tamoxifen—pancreatic cancer	0.0105	0.015	CbGbCtD
Omeprazole—CYP1A2—Erlotinib—pancreatic cancer	0.0102	0.0146	CbGbCtD
Omeprazole—ABCC3—bile duct—pancreatic cancer	0.00997	0.196	CbGeAlD
Omeprazole—CYP2D6—Tamoxifen—pancreatic cancer	0.00991	0.0141	CbGbCtD
Omeprazole—ABCB1—Gemcitabine—pancreatic cancer	0.00906	0.0129	CbGbCtD
Omeprazole—ABCB1—Erlotinib—pancreatic cancer	0.00895	0.0127	CbGbCtD
Omeprazole—CYP1A2—Fluorouracil—pancreatic cancer	0.00887	0.0126	CbGbCtD
Omeprazole—CYP2D6—Erlotinib—pancreatic cancer	0.00843	0.012	CbGbCtD
Omeprazole—ABCB1—Irinotecan—pancreatic cancer	0.00808	0.0115	CbGbCtD
Omeprazole—CYP2C9—Fluorouracil—pancreatic cancer	0.00799	0.0114	CbGbCtD
Omeprazole—CYP3A4—Tamoxifen—pancreatic cancer	0.0063	0.00897	CbGbCtD
Omeprazole—ABCB1—Docetaxel—pancreatic cancer	0.00592	0.00843	CbGbCtD
Omeprazole—ABCB1—Sunitinib—pancreatic cancer	0.00589	0.00839	CbGbCtD
Omeprazole—CYP3A4—Erlotinib—pancreatic cancer	0.00536	0.00763	CbGbCtD
Omeprazole—CYP3A4—Irinotecan—pancreatic cancer	0.00484	0.00689	CbGbCtD
Omeprazole—ABCB1—Doxorubicin—pancreatic cancer	0.00441	0.00628	CbGbCtD
Omeprazole—CYP2D6—Doxorubicin—pancreatic cancer	0.00416	0.00592	CbGbCtD
Omeprazole—ATP4B—digestive system—pancreatic cancer	0.00378	0.0743	CbGeAlD
Omeprazole—CYP3A4—Docetaxel—pancreatic cancer	0.00355	0.00505	CbGbCtD
Omeprazole—CYP3A4—Sunitinib—pancreatic cancer	0.00353	0.00503	CbGbCtD
Omeprazole—CYP3A4—Doxorubicin—pancreatic cancer	0.00264	0.00376	CbGbCtD
Omeprazole—ABCC3—gall bladder—pancreatic cancer	0.00213	0.0418	CbGeAlD
Omeprazole—ATP4A—digestive system—pancreatic cancer	0.00165	0.0323	CbGeAlD
Omeprazole—CYP2C18—digestive system—pancreatic cancer	0.00135	0.0266	CbGeAlD
Omeprazole—ABCC3—digestive system—pancreatic cancer	0.000837	0.0164	CbGeAlD
Omeprazole—CYP1B1—digestive system—pancreatic cancer	0.000655	0.0129	CbGeAlD
Omeprazole—CYP2C19—digestive system—pancreatic cancer	0.000575	0.0113	CbGeAlD
Omeprazole—CYP1A2—digestive system—pancreatic cancer	0.000469	0.00922	CbGeAlD
Omeprazole—CYP1A1—digestive system—pancreatic cancer	0.000463	0.0091	CbGeAlD
Omeprazole—CYP2C9—digestive system—pancreatic cancer	0.000446	0.00875	CbGeAlD
Omeprazole—ABCB1—islet of Langerhans—pancreatic cancer	0.000401	0.00787	CbGeAlD
Omeprazole—CYP3A4—digestive system—pancreatic cancer	0.00034	0.00668	CbGeAlD
Omeprazole—CYP2D6—digestive system—pancreatic cancer	0.000334	0.00657	CbGeAlD
Omeprazole—ABCB1—pancreas—pancreatic cancer	0.000282	0.00553	CbGeAlD
Omeprazole—ABCB1—digestive system—pancreatic cancer	0.000241	0.00473	CbGeAlD
Omeprazole—Pancytopenia—Doxorubicin—pancreatic cancer	8.78e-05	0.000473	CcSEcCtD
Omeprazole—Renal failure—Epirubicin—pancreatic cancer	8.76e-05	0.000472	CcSEcCtD
Omeprazole—Asthenia—Irinotecan—pancreatic cancer	8.74e-05	0.000472	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	8.73e-05	0.000471	CcSEcCtD
Omeprazole—Stomatitis—Epirubicin—pancreatic cancer	8.68e-05	0.000468	CcSEcCtD
Omeprazole—Jaundice—Epirubicin—pancreatic cancer	8.68e-05	0.000468	CcSEcCtD
Omeprazole—Conjunctivitis—Epirubicin—pancreatic cancer	8.66e-05	0.000467	CcSEcCtD
Omeprazole—Urinary tract infection—Epirubicin—pancreatic cancer	8.66e-05	0.000467	CcSEcCtD
Omeprazole—Neutropenia—Doxorubicin—pancreatic cancer	8.64e-05	0.000466	CcSEcCtD
Omeprazole—Dysuria—Doxorubicin—pancreatic cancer	8.64e-05	0.000466	CcSEcCtD
Omeprazole—Hypersensitivity—Fluorouracil—pancreatic cancer	8.6e-05	0.000464	CcSEcCtD
Omeprazole—Dry mouth—Docetaxel—pancreatic cancer	8.59e-05	0.000463	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	8.59e-05	0.000463	CcSEcCtD
Omeprazole—Pollakiuria—Doxorubicin—pancreatic cancer	8.54e-05	0.000461	CcSEcCtD
Omeprazole—Asthenia—Gemcitabine—pancreatic cancer	8.52e-05	0.000459	CcSEcCtD
Omeprazole—Haematuria—Epirubicin—pancreatic cancer	8.49e-05	0.000458	CcSEcCtD
Omeprazole—Confusional state—Docetaxel—pancreatic cancer	8.49e-05	0.000458	CcSEcCtD
Omeprazole—Photosensitivity reaction—Doxorubicin—pancreatic cancer	8.44e-05	0.000455	CcSEcCtD
Omeprazole—Hepatobiliary disease—Epirubicin—pancreatic cancer	8.42e-05	0.000454	CcSEcCtD
Omeprazole—Anaphylactic shock—Docetaxel—pancreatic cancer	8.42e-05	0.000454	CcSEcCtD
Omeprazole—Weight increased—Doxorubicin—pancreatic cancer	8.41e-05	0.000454	CcSEcCtD
Omeprazole—Epistaxis—Epirubicin—pancreatic cancer	8.4e-05	0.000453	CcSEcCtD
Omeprazole—Pruritus—Gemcitabine—pancreatic cancer	8.4e-05	0.000453	CcSEcCtD
Omeprazole—Infection—Docetaxel—pancreatic cancer	8.37e-05	0.000451	CcSEcCtD
Omeprazole—Weight decreased—Doxorubicin—pancreatic cancer	8.36e-05	0.000451	CcSEcCtD
Omeprazole—Sinusitis—Epirubicin—pancreatic cancer	8.36e-05	0.000451	CcSEcCtD
Omeprazole—Diarrhoea—Irinotecan—pancreatic cancer	8.34e-05	0.00045	CcSEcCtD
Omeprazole—Agranulocytosis—Epirubicin—pancreatic cancer	8.31e-05	0.000448	CcSEcCtD
Omeprazole—Shock—Docetaxel—pancreatic cancer	8.29e-05	0.000447	CcSEcCtD
Omeprazole—Nervous system disorder—Docetaxel—pancreatic cancer	8.26e-05	0.000446	CcSEcCtD
Omeprazole—Pruritus—Fluorouracil—pancreatic cancer	8.26e-05	0.000445	CcSEcCtD
Omeprazole—Thrombocytopenia—Docetaxel—pancreatic cancer	8.25e-05	0.000445	CcSEcCtD
Omeprazole—Infestation NOS—Doxorubicin—pancreatic cancer	8.24e-05	0.000445	CcSEcCtD
Omeprazole—Infestation—Doxorubicin—pancreatic cancer	8.24e-05	0.000445	CcSEcCtD
Omeprazole—Tachycardia—Docetaxel—pancreatic cancer	8.22e-05	0.000443	CcSEcCtD
Omeprazole—Skin disorder—Docetaxel—pancreatic cancer	8.18e-05	0.000441	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.17e-05	0.000441	CcSEcCtD
Omeprazole—Bradycardia—Epirubicin—pancreatic cancer	8.14e-05	0.000439	CcSEcCtD
Omeprazole—Diarrhoea—Gemcitabine—pancreatic cancer	8.12e-05	0.000438	CcSEcCtD
Omeprazole—Renal failure—Doxorubicin—pancreatic cancer	8.1e-05	0.000437	CcSEcCtD
Omeprazole—Dizziness—Irinotecan—pancreatic cancer	8.06e-05	0.000435	CcSEcCtD
Omeprazole—Stomatitis—Doxorubicin—pancreatic cancer	8.03e-05	0.000433	CcSEcCtD
Omeprazole—Jaundice—Doxorubicin—pancreatic cancer	8.03e-05	0.000433	CcSEcCtD
Omeprazole—Anorexia—Docetaxel—pancreatic cancer	8.03e-05	0.000433	CcSEcCtD
Omeprazole—Rhinitis—Epirubicin—pancreatic cancer	8.02e-05	0.000432	CcSEcCtD
Omeprazole—Conjunctivitis—Doxorubicin—pancreatic cancer	8.01e-05	0.000432	CcSEcCtD
Omeprazole—Urinary tract infection—Doxorubicin—pancreatic cancer	8.01e-05	0.000432	CcSEcCtD
Omeprazole—Hepatitis—Epirubicin—pancreatic cancer	8e-05	0.000431	CcSEcCtD
Omeprazole—Diarrhoea—Fluorouracil—pancreatic cancer	7.99e-05	0.000431	CcSEcCtD
Omeprazole—Hypoaesthesia—Epirubicin—pancreatic cancer	7.96e-05	0.000429	CcSEcCtD
Omeprazole—Pharyngitis—Epirubicin—pancreatic cancer	7.94e-05	0.000428	CcSEcCtD
Omeprazole—Urinary tract disorder—Epirubicin—pancreatic cancer	7.9e-05	0.000426	CcSEcCtD
Omeprazole—Oedema peripheral—Epirubicin—pancreatic cancer	7.88e-05	0.000425	CcSEcCtD
Omeprazole—Haematuria—Doxorubicin—pancreatic cancer	7.86e-05	0.000424	CcSEcCtD
Omeprazole—Connective tissue disorder—Epirubicin—pancreatic cancer	7.86e-05	0.000424	CcSEcCtD
Omeprazole—Urethral disorder—Epirubicin—pancreatic cancer	7.84e-05	0.000423	CcSEcCtD
Omeprazole—Hepatobiliary disease—Doxorubicin—pancreatic cancer	7.8e-05	0.00042	CcSEcCtD
Omeprazole—Epistaxis—Doxorubicin—pancreatic cancer	7.77e-05	0.000419	CcSEcCtD
Omeprazole—Vomiting—Irinotecan—pancreatic cancer	7.75e-05	0.000418	CcSEcCtD
Omeprazole—Sinusitis—Doxorubicin—pancreatic cancer	7.73e-05	0.000417	CcSEcCtD
Omeprazole—Dizziness—Fluorouracil—pancreatic cancer	7.72e-05	0.000416	CcSEcCtD
Omeprazole—Visual impairment—Epirubicin—pancreatic cancer	7.71e-05	0.000416	CcSEcCtD
Omeprazole—Agranulocytosis—Doxorubicin—pancreatic cancer	7.69e-05	0.000415	CcSEcCtD
Omeprazole—Rash—Irinotecan—pancreatic cancer	7.68e-05	0.000414	CcSEcCtD
Omeprazole—Dermatitis—Irinotecan—pancreatic cancer	7.68e-05	0.000414	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.67e-05	0.000414	CcSEcCtD
Omeprazole—Headache—Irinotecan—pancreatic cancer	7.63e-05	0.000412	CcSEcCtD
Omeprazole—Insomnia—Docetaxel—pancreatic cancer	7.62e-05	0.000411	CcSEcCtD
Omeprazole—Paraesthesia—Docetaxel—pancreatic cancer	7.56e-05	0.000408	CcSEcCtD
Omeprazole—Erythema multiforme—Epirubicin—pancreatic cancer	7.56e-05	0.000408	CcSEcCtD
Omeprazole—Vomiting—Gemcitabine—pancreatic cancer	7.55e-05	0.000407	CcSEcCtD
Omeprazole—Bradycardia—Doxorubicin—pancreatic cancer	7.53e-05	0.000406	CcSEcCtD
Omeprazole—Dyspnoea—Docetaxel—pancreatic cancer	7.51e-05	0.000405	CcSEcCtD
Omeprazole—Somnolence—Docetaxel—pancreatic cancer	7.49e-05	0.000404	CcSEcCtD
Omeprazole—Rash—Gemcitabine—pancreatic cancer	7.48e-05	0.000404	CcSEcCtD
Omeprazole—Dermatitis—Gemcitabine—pancreatic cancer	7.48e-05	0.000403	CcSEcCtD
Omeprazole—Eye disorder—Epirubicin—pancreatic cancer	7.47e-05	0.000403	CcSEcCtD
Omeprazole—Tinnitus—Epirubicin—pancreatic cancer	7.46e-05	0.000402	CcSEcCtD
Omeprazole—Headache—Gemcitabine—pancreatic cancer	7.44e-05	0.000401	CcSEcCtD
Omeprazole—Flushing—Epirubicin—pancreatic cancer	7.42e-05	0.0004	CcSEcCtD
Omeprazole—Vomiting—Fluorouracil—pancreatic cancer	7.42e-05	0.0004	CcSEcCtD
Omeprazole—Rhinitis—Doxorubicin—pancreatic cancer	7.42e-05	0.0004	CcSEcCtD
Omeprazole—Dyspepsia—Docetaxel—pancreatic cancer	7.41e-05	0.0004	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—pancreatic cancer	7.4e-05	0.000399	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—pancreatic cancer	7.36e-05	0.000397	CcSEcCtD
Omeprazole—Rash—Fluorouracil—pancreatic cancer	7.36e-05	0.000397	CcSEcCtD
Omeprazole—Dermatitis—Fluorouracil—pancreatic cancer	7.35e-05	0.000396	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—pancreatic cancer	7.34e-05	0.000396	CcSEcCtD
Omeprazole—Decreased appetite—Docetaxel—pancreatic cancer	7.32e-05	0.000395	CcSEcCtD
Omeprazole—Headache—Fluorouracil—pancreatic cancer	7.31e-05	0.000394	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—pancreatic cancer	7.31e-05	0.000394	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—pancreatic cancer	7.29e-05	0.000393	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Docetaxel—pancreatic cancer	7.27e-05	0.000392	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—pancreatic cancer	7.27e-05	0.000392	CcSEcCtD
Omeprazole—Fatigue—Docetaxel—pancreatic cancer	7.26e-05	0.000392	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—pancreatic cancer	7.25e-05	0.000391	CcSEcCtD
Omeprazole—Nausea—Irinotecan—pancreatic cancer	7.24e-05	0.00039	CcSEcCtD
Omeprazole—Immune system disorder—Epirubicin—pancreatic cancer	7.22e-05	0.00039	CcSEcCtD
Omeprazole—Mediastinal disorder—Epirubicin—pancreatic cancer	7.21e-05	0.000389	CcSEcCtD
Omeprazole—Constipation—Docetaxel—pancreatic cancer	7.2e-05	0.000388	CcSEcCtD
Omeprazole—Pain—Docetaxel—pancreatic cancer	7.2e-05	0.000388	CcSEcCtD
Omeprazole—Chills—Epirubicin—pancreatic cancer	7.18e-05	0.000387	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—pancreatic cancer	7.13e-05	0.000385	CcSEcCtD
Omeprazole—Alopecia—Epirubicin—pancreatic cancer	7.07e-05	0.000381	CcSEcCtD
Omeprazole—Nausea—Gemcitabine—pancreatic cancer	7.05e-05	0.00038	CcSEcCtD
Omeprazole—Mental disorder—Epirubicin—pancreatic cancer	7.01e-05	0.000378	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—pancreatic cancer	7e-05	0.000377	CcSEcCtD
Omeprazole—Malnutrition—Epirubicin—pancreatic cancer	6.96e-05	0.000375	CcSEcCtD
Omeprazole—Feeling abnormal—Docetaxel—pancreatic cancer	6.94e-05	0.000374	CcSEcCtD
Omeprazole—Nausea—Fluorouracil—pancreatic cancer	6.93e-05	0.000374	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—pancreatic cancer	6.91e-05	0.000373	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—pancreatic cancer	6.9e-05	0.000372	CcSEcCtD
Omeprazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.89e-05	0.000371	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—pancreatic cancer	6.87e-05	0.00037	CcSEcCtD
Omeprazole—Flatulence—Epirubicin—pancreatic cancer	6.86e-05	0.00037	CcSEcCtD
Omeprazole—Tension—Epirubicin—pancreatic cancer	6.83e-05	0.000368	CcSEcCtD
Omeprazole—Dysgeusia—Epirubicin—pancreatic cancer	6.82e-05	0.000368	CcSEcCtD
Omeprazole—Nervousness—Epirubicin—pancreatic cancer	6.76e-05	0.000365	CcSEcCtD
Omeprazole—Back pain—Epirubicin—pancreatic cancer	6.73e-05	0.000363	CcSEcCtD
Omeprazole—Muscle spasms—Epirubicin—pancreatic cancer	6.69e-05	0.000361	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—pancreatic cancer	6.68e-05	0.00036	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—pancreatic cancer	6.67e-05	0.00036	CcSEcCtD
Omeprazole—Abdominal pain—Docetaxel—pancreatic cancer	6.66e-05	0.000359	CcSEcCtD
Omeprazole—Body temperature increased—Docetaxel—pancreatic cancer	6.66e-05	0.000359	CcSEcCtD
Omeprazole—Chills—Doxorubicin—pancreatic cancer	6.64e-05	0.000358	CcSEcCtD
Omeprazole—Vision blurred—Epirubicin—pancreatic cancer	6.56e-05	0.000354	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—pancreatic cancer	6.54e-05	0.000353	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—pancreatic cancer	6.48e-05	0.00035	CcSEcCtD
Omeprazole—Ill-defined disorder—Epirubicin—pancreatic cancer	6.46e-05	0.000348	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—pancreatic cancer	6.44e-05	0.000347	CcSEcCtD
Omeprazole—Anaemia—Epirubicin—pancreatic cancer	6.43e-05	0.000347	CcSEcCtD
Omeprazole—Agitation—Epirubicin—pancreatic cancer	6.4e-05	0.000345	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—pancreatic cancer	6.35e-05	0.000342	CcSEcCtD
Omeprazole—Tension—Doxorubicin—pancreatic cancer	6.32e-05	0.000341	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—pancreatic cancer	6.31e-05	0.00034	CcSEcCtD
Omeprazole—Malaise—Epirubicin—pancreatic cancer	6.28e-05	0.000339	CcSEcCtD
Omeprazole—Nervousness—Doxorubicin—pancreatic cancer	6.26e-05	0.000337	CcSEcCtD
Omeprazole—Vertigo—Epirubicin—pancreatic cancer	6.25e-05	0.000337	CcSEcCtD
Omeprazole—Leukopenia—Epirubicin—pancreatic cancer	6.23e-05	0.000336	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—pancreatic cancer	6.23e-05	0.000336	CcSEcCtD
Omeprazole—Hypersensitivity—Docetaxel—pancreatic cancer	6.21e-05	0.000335	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—pancreatic cancer	6.19e-05	0.000334	CcSEcCtD
Omeprazole—Palpitations—Epirubicin—pancreatic cancer	6.15e-05	0.000332	CcSEcCtD
Omeprazole—Cough—Epirubicin—pancreatic cancer	6.07e-05	0.000328	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—pancreatic cancer	6.07e-05	0.000327	CcSEcCtD
Omeprazole—Asthenia—Docetaxel—pancreatic cancer	6.04e-05	0.000326	CcSEcCtD
Omeprazole—Hypertension—Epirubicin—pancreatic cancer	6.01e-05	0.000324	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—pancreatic cancer	5.98e-05	0.000322	CcSEcCtD
Omeprazole—Pruritus—Docetaxel—pancreatic cancer	5.96e-05	0.000321	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—pancreatic cancer	5.95e-05	0.000321	CcSEcCtD
Omeprazole—Chest pain—Epirubicin—pancreatic cancer	5.93e-05	0.00032	CcSEcCtD
Omeprazole—Arthralgia—Epirubicin—pancreatic cancer	5.93e-05	0.00032	CcSEcCtD
Omeprazole—Myalgia—Epirubicin—pancreatic cancer	5.93e-05	0.00032	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—pancreatic cancer	5.92e-05	0.000319	CcSEcCtD
Omeprazole—Anxiety—Epirubicin—pancreatic cancer	5.91e-05	0.000319	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	5.89e-05	0.000317	CcSEcCtD
Omeprazole—Discomfort—Epirubicin—pancreatic cancer	5.86e-05	0.000316	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—pancreatic cancer	5.81e-05	0.000313	CcSEcCtD
Omeprazole—Dry mouth—Epirubicin—pancreatic cancer	5.8e-05	0.000313	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—pancreatic cancer	5.79e-05	0.000312	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—pancreatic cancer	5.77e-05	0.000311	CcSEcCtD
Omeprazole—Diarrhoea—Docetaxel—pancreatic cancer	5.76e-05	0.000311	CcSEcCtD
Omeprazole—Confusional state—Epirubicin—pancreatic cancer	5.73e-05	0.000309	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—pancreatic cancer	5.69e-05	0.000307	CcSEcCtD
Omeprazole—Anaphylactic shock—Epirubicin—pancreatic cancer	5.68e-05	0.000306	CcSEcCtD
Omeprazole—Infection—Epirubicin—pancreatic cancer	5.64e-05	0.000304	CcSEcCtD
Omeprazole—Cough—Doxorubicin—pancreatic cancer	5.62e-05	0.000303	CcSEcCtD
Omeprazole—Shock—Epirubicin—pancreatic cancer	5.59e-05	0.000301	CcSEcCtD
Omeprazole—Nervous system disorder—Epirubicin—pancreatic cancer	5.57e-05	0.0003	CcSEcCtD
Omeprazole—Dizziness—Docetaxel—pancreatic cancer	5.57e-05	0.0003	CcSEcCtD
Omeprazole—Thrombocytopenia—Epirubicin—pancreatic cancer	5.56e-05	0.0003	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—pancreatic cancer	5.56e-05	0.0003	CcSEcCtD
Omeprazole—Tachycardia—Epirubicin—pancreatic cancer	5.55e-05	0.000299	CcSEcCtD
Omeprazole—Skin disorder—Epirubicin—pancreatic cancer	5.52e-05	0.000298	CcSEcCtD
Omeprazole—Hyperhidrosis—Epirubicin—pancreatic cancer	5.49e-05	0.000296	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—pancreatic cancer	5.48e-05	0.000296	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—pancreatic cancer	5.48e-05	0.000296	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—pancreatic cancer	5.48e-05	0.000296	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—pancreatic cancer	5.46e-05	0.000295	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	5.45e-05	0.000294	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—pancreatic cancer	5.42e-05	0.000292	CcSEcCtD
Omeprazole—Anorexia—Epirubicin—pancreatic cancer	5.42e-05	0.000292	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—pancreatic cancer	5.36e-05	0.000289	CcSEcCtD
Omeprazole—Vomiting—Docetaxel—pancreatic cancer	5.36e-05	0.000289	CcSEcCtD
Omeprazole—Rash—Docetaxel—pancreatic cancer	5.31e-05	0.000286	CcSEcCtD
Omeprazole—Dermatitis—Docetaxel—pancreatic cancer	5.31e-05	0.000286	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—pancreatic cancer	5.3e-05	0.000286	CcSEcCtD
Omeprazole—Headache—Docetaxel—pancreatic cancer	5.28e-05	0.000285	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—pancreatic cancer	5.26e-05	0.000284	CcSEcCtD
Omeprazole—Infection—Doxorubicin—pancreatic cancer	5.22e-05	0.000282	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.18e-05	0.000279	CcSEcCtD
Omeprazole—Shock—Doxorubicin—pancreatic cancer	5.17e-05	0.000279	CcSEcCtD
Omeprazole—Nervous system disorder—Doxorubicin—pancreatic cancer	5.16e-05	0.000278	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.15e-05	0.000278	CcSEcCtD
Omeprazole—Insomnia—Epirubicin—pancreatic cancer	5.14e-05	0.000277	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—pancreatic cancer	5.13e-05	0.000277	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—pancreatic cancer	5.11e-05	0.000275	CcSEcCtD
Omeprazole—Paraesthesia—Epirubicin—pancreatic cancer	5.1e-05	0.000275	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.08e-05	0.000274	CcSEcCtD
Omeprazole—Dyspnoea—Epirubicin—pancreatic cancer	5.07e-05	0.000273	CcSEcCtD
Omeprazole—Somnolence—Epirubicin—pancreatic cancer	5.05e-05	0.000272	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—pancreatic cancer	5.01e-05	0.00027	CcSEcCtD
Omeprazole—Nausea—Docetaxel—pancreatic cancer	5e-05	0.00027	CcSEcCtD
Omeprazole—Dyspepsia—Epirubicin—pancreatic cancer	5e-05	0.00027	CcSEcCtD
Omeprazole—Decreased appetite—Epirubicin—pancreatic cancer	4.94e-05	0.000266	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.91e-05	0.000265	CcSEcCtD
Omeprazole—Fatigue—Epirubicin—pancreatic cancer	4.9e-05	0.000264	CcSEcCtD
Omeprazole—Constipation—Epirubicin—pancreatic cancer	4.86e-05	0.000262	CcSEcCtD
Omeprazole—Pain—Epirubicin—pancreatic cancer	4.86e-05	0.000262	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.79e-05	0.000258	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—pancreatic cancer	4.75e-05	0.000256	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—pancreatic cancer	4.72e-05	0.000255	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—pancreatic cancer	4.69e-05	0.000253	CcSEcCtD
Omeprazole—Feeling abnormal—Epirubicin—pancreatic cancer	4.68e-05	0.000253	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—pancreatic cancer	4.67e-05	0.000252	CcSEcCtD
Omeprazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.65e-05	0.000251	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—pancreatic cancer	4.63e-05	0.00025	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—pancreatic cancer	4.57e-05	0.000246	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.54e-05	0.000245	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—pancreatic cancer	4.53e-05	0.000244	CcSEcCtD
Omeprazole—Urticaria—Epirubicin—pancreatic cancer	4.51e-05	0.000243	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—pancreatic cancer	4.5e-05	0.000242	CcSEcCtD
Omeprazole—Pain—Doxorubicin—pancreatic cancer	4.5e-05	0.000242	CcSEcCtD
Omeprazole—Body temperature increased—Epirubicin—pancreatic cancer	4.49e-05	0.000242	CcSEcCtD
Omeprazole—Abdominal pain—Epirubicin—pancreatic cancer	4.49e-05	0.000242	CcSEcCtD
Omeprazole—Feeling abnormal—Doxorubicin—pancreatic cancer	4.33e-05	0.000234	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.3e-05	0.000232	CcSEcCtD
Omeprazole—Hypersensitivity—Epirubicin—pancreatic cancer	4.19e-05	0.000226	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—pancreatic cancer	4.18e-05	0.000225	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—pancreatic cancer	4.16e-05	0.000224	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—pancreatic cancer	4.16e-05	0.000224	CcSEcCtD
Omeprazole—Asthenia—Epirubicin—pancreatic cancer	4.08e-05	0.00022	CcSEcCtD
Omeprazole—Pruritus—Epirubicin—pancreatic cancer	4.02e-05	0.000217	CcSEcCtD
Omeprazole—Diarrhoea—Epirubicin—pancreatic cancer	3.89e-05	0.00021	CcSEcCtD
Omeprazole—Hypersensitivity—Doxorubicin—pancreatic cancer	3.87e-05	0.000209	CcSEcCtD
Omeprazole—Asthenia—Doxorubicin—pancreatic cancer	3.77e-05	0.000203	CcSEcCtD
Omeprazole—Dizziness—Epirubicin—pancreatic cancer	3.76e-05	0.000203	CcSEcCtD
Omeprazole—Pruritus—Doxorubicin—pancreatic cancer	3.72e-05	0.000201	CcSEcCtD
Omeprazole—Vomiting—Epirubicin—pancreatic cancer	3.61e-05	0.000195	CcSEcCtD
Omeprazole—Diarrhoea—Doxorubicin—pancreatic cancer	3.6e-05	0.000194	CcSEcCtD
Omeprazole—Rash—Epirubicin—pancreatic cancer	3.58e-05	0.000193	CcSEcCtD
Omeprazole—Dermatitis—Epirubicin—pancreatic cancer	3.58e-05	0.000193	CcSEcCtD
Omeprazole—Headache—Epirubicin—pancreatic cancer	3.56e-05	0.000192	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—pancreatic cancer	3.48e-05	0.000187	CcSEcCtD
Omeprazole—Nausea—Epirubicin—pancreatic cancer	3.37e-05	0.000182	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—pancreatic cancer	3.34e-05	0.00018	CcSEcCtD
Omeprazole—Rash—Doxorubicin—pancreatic cancer	3.31e-05	0.000179	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—pancreatic cancer	3.31e-05	0.000179	CcSEcCtD
Omeprazole—Headache—Doxorubicin—pancreatic cancer	3.29e-05	0.000178	CcSEcCtD
Omeprazole—Nausea—Doxorubicin—pancreatic cancer	3.12e-05	0.000168	CcSEcCtD
Omeprazole—CYP11A1—Metabolism—APOE—pancreatic cancer	1.53e-05	0.000251	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.52e-05	0.000248	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.5e-05	0.000246	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TYMP—pancreatic cancer	1.5e-05	0.000246	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ARG2—pancreatic cancer	1.5e-05	0.000245	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GCG—pancreatic cancer	1.49e-05	0.000243	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.45e-05	0.000237	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.43e-05	0.000234	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.41e-05	0.000231	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CD44—pancreatic cancer	1.41e-05	0.000231	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.4e-05	0.000229	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—STK11—pancreatic cancer	1.4e-05	0.000228	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.4e-05	0.000228	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CG—pancreatic cancer	1.38e-05	0.000226	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.38e-05	0.000225	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GCG—pancreatic cancer	1.35e-05	0.000221	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.35e-05	0.000221	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.34e-05	0.000219	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PPARG—pancreatic cancer	1.33e-05	0.000218	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—APOE—pancreatic cancer	1.33e-05	0.000217	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GLP1R—pancreatic cancer	1.32e-05	0.000216	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.31e-05	0.000214	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TYMP—pancreatic cancer	1.31e-05	0.000214	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—DPYD—pancreatic cancer	1.3e-05	0.000212	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—APOE—pancreatic cancer	1.29e-05	0.000211	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.28e-05	0.00021	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.28e-05	0.000209	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—STK11—pancreatic cancer	1.27e-05	0.000208	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.26e-05	0.000205	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.24e-05	0.000203	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.23e-05	0.000202	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	1.23e-05	0.000202	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.22e-05	0.0002	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.22e-05	0.0002	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.22e-05	0.000199	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CD—pancreatic cancer	1.22e-05	0.000199	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.21e-05	0.000198	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—TYMS—pancreatic cancer	1.2e-05	0.000197	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CG—pancreatic cancer	1.2e-05	0.000196	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.2e-05	0.000196	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.19e-05	0.000195	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.19e-05	0.000195	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.19e-05	0.000194	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.18e-05	0.000193	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CG—pancreatic cancer	1.16e-05	0.00019	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PPARG—pancreatic cancer	1.15e-05	0.000189	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.13e-05	0.000185	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PPARG—pancreatic cancer	1.12e-05	0.000184	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.12e-05	0.000183	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.11e-05	0.000181	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—TYMS—pancreatic cancer	1.09e-05	0.000179	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.09e-05	0.000178	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.08e-05	0.000177	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.08e-05	0.000177	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.07e-05	0.000175	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.06e-05	0.000174	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.06e-05	0.000174	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CB—pancreatic cancer	1.06e-05	0.000173	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.05e-05	0.000172	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.05e-05	0.000172	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CD—pancreatic cancer	1.05e-05	0.000172	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—pancreatic cancer	1.05e-05	0.000172	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.04e-05	0.000171	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—DPYD—pancreatic cancer	1.04e-05	0.00017	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CD—pancreatic cancer	1.02e-05	0.000167	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.01e-05	0.000165	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.01e-05	0.000165	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.98e-06	0.000163	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GLP1R—pancreatic cancer	9.94e-06	0.000163	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GLP1R—pancreatic cancer	9.85e-06	0.000161	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SLC2A2—pancreatic cancer	9.84e-06	0.000161	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.83e-06	0.000161	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—DPYD—pancreatic cancer	9.77e-06	0.00016	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—APOE—pancreatic cancer	9.77e-06	0.00016	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—DPYD—pancreatic cancer	9.69e-06	0.000158	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.63e-06	0.000158	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CD44—pancreatic cancer	9.54e-06	0.000156	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	9.35e-06	0.000153	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	9.28e-06	0.000152	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	9.26e-06	0.000151	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.25e-06	0.000151	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ARG2—pancreatic cancer	9.22e-06	0.000151	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	9.2e-06	0.00015	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CB—pancreatic cancer	9.17e-06	0.00015	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTEN—pancreatic cancer	9.15e-06	0.00015	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GCG—pancreatic cancer	9.15e-06	0.00015	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.1e-06	0.000149	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—pancreatic cancer	9.08e-06	0.000149	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CB—pancreatic cancer	8.92e-06	0.000146	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	8.9e-06	0.000146	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—APOE—pancreatic cancer	8.89e-06	0.000145	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—pancreatic cancer	8.84e-06	0.000145	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CG—pancreatic cancer	8.82e-06	0.000144	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.78e-06	0.000144	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.77e-06	0.000144	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CD44—pancreatic cancer	8.75e-06	0.000143	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.62e-06	0.000141	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—STK11—pancreatic cancer	8.6e-06	0.000141	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.57e-06	0.00014	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PPARG—pancreatic cancer	8.51e-06	0.000139	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.49e-06	0.000139	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GLP1R—pancreatic cancer	8.42e-06	0.000138	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GCG—pancreatic cancer	8.39e-06	0.000137	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—DPYD—pancreatic cancer	8.28e-06	0.000135	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.08e-06	0.000132	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TYMP—pancreatic cancer	8.06e-06	0.000132	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CG—pancreatic cancer	8.02e-06	0.000131	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8e-06	0.000131	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTEN—pancreatic cancer	7.92e-06	0.00013	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—STK11—pancreatic cancer	7.89e-06	0.000129	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	7.86e-06	0.000129	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CD44—pancreatic cancer	7.81e-06	0.000128	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.78e-06	0.000127	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CD—pancreatic cancer	7.75e-06	0.000127	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PPARG—pancreatic cancer	7.74e-06	0.000127	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTEN—pancreatic cancer	7.71e-06	0.000126	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.65e-06	0.000125	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CD44—pancreatic cancer	7.62e-06	0.000125	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.58e-06	0.000124	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.51e-06	0.000123	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GCG—pancreatic cancer	7.49e-06	0.000122	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.4e-06	0.000121	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—TYMS—pancreatic cancer	7.4e-06	0.000121	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GCG—pancreatic cancer	7.31e-06	0.00012	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CD44—pancreatic cancer	7.18e-06	0.000117	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CD44—pancreatic cancer	7.12e-06	0.000116	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CD—pancreatic cancer	7.05e-06	0.000115	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—STK11—pancreatic cancer	7.04e-06	0.000115	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.97e-06	0.000114	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.91e-06	0.000113	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GCG—pancreatic cancer	6.89e-06	0.000113	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—STK11—pancreatic cancer	6.87e-06	0.000112	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.84e-06	0.000112	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GCG—pancreatic cancer	6.83e-06	0.000112	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TYMS—pancreatic cancer	6.78e-06	0.000111	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CB—pancreatic cancer	6.76e-06	0.000111	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—pancreatic cancer	6.7e-06	0.00011	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.61e-06	0.000108	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.5e-06	0.000106	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—STK11—pancreatic cancer	6.48e-06	0.000106	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—pancreatic cancer	6.46e-06	0.000106	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—STK11—pancreatic cancer	6.42e-06	0.000105	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—DPYD—pancreatic cancer	6.39e-06	0.000105	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CB—pancreatic cancer	6.15e-06	0.000101	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—pancreatic cancer	6.09e-06	9.96e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CD44—pancreatic cancer	6.09e-06	9.95e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	6.06e-06	9.92e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TYMS—pancreatic cancer	6.06e-06	9.9e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.03e-06	9.86e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—APOE—pancreatic cancer	6.02e-06	9.84e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.96e-06	9.75e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TYMS—pancreatic cancer	5.91e-06	9.67e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.9e-06	9.66e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTEN—pancreatic cancer	5.84e-06	9.55e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GCG—pancreatic cancer	5.83e-06	9.54e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.7e-06	9.32e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—pancreatic cancer	5.59e-06	9.14e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TYMS—pancreatic cancer	5.57e-06	9.11e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TYMS—pancreatic cancer	5.52e-06	9.03e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—APOE—pancreatic cancer	5.52e-06	9.02e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—STK11—pancreatic cancer	5.49e-06	8.97e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—pancreatic cancer	5.44e-06	8.89e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	5.43e-06	8.88e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTEN—pancreatic cancer	5.31e-06	8.69e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AKT1—pancreatic cancer	5.28e-06	8.63e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARG—pancreatic cancer	5.24e-06	8.57e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.22e-06	8.54e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.15e-06	8.42e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	4.98e-06	8.14e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—APOE—pancreatic cancer	4.93e-06	8.06e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—APOE—pancreatic cancer	4.81e-06	7.86e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARG—pancreatic cancer	4.81e-06	7.86e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	4.77e-06	7.81e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TYMS—pancreatic cancer	4.72e-06	7.72e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CD44—pancreatic cancer	4.7e-06	7.68e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.66e-06	7.63e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—pancreatic cancer	4.57e-06	7.47e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—APOE—pancreatic cancer	4.53e-06	7.41e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GCG—pancreatic cancer	4.5e-06	7.36e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—APOE—pancreatic cancer	4.49e-06	7.34e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	4.44e-06	7.27e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—pancreatic cancer	4.44e-06	7.26e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	4.38e-06	7.16e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CG—pancreatic cancer	4.34e-06	7.1e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARG—pancreatic cancer	4.29e-06	7.02e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.25e-06	6.95e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—STK11—pancreatic cancer	4.23e-06	6.92e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARG—pancreatic cancer	4.19e-06	6.85e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	4.16e-06	6.81e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—pancreatic cancer	4.12e-06	6.74e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	4.12e-06	6.74e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	4.09e-06	6.69e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	4.05e-06	6.63e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.95e-06	6.45e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.91e-06	6.4e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.91e-06	6.39e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APOE—pancreatic cancer	3.84e-06	6.28e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.82e-06	6.24e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.81e-06	6.24e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.78e-06	6.18e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—pancreatic cancer	3.75e-06	6.13e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.64e-06	5.96e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.63e-06	5.94e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTEN—pancreatic cancer	3.6e-06	5.88e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.59e-06	5.88e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.56e-06	5.83e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	3.46e-06	5.66e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	3.41e-06	5.57e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—pancreatic cancer	3.37e-06	5.52e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—pancreatic cancer	3.37e-06	5.5e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARG—pancreatic cancer	3.34e-06	5.47e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.32e-06	5.44e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTEN—pancreatic cancer	3.3e-06	5.39e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—pancreatic cancer	3.29e-06	5.39e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.13e-06	5.12e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	3.11e-06	5.08e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.1e-06	5.08e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—pancreatic cancer	3.08e-06	5.03e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—pancreatic cancer	3.06e-06	5.01e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	3.04e-06	4.98e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOE—pancreatic cancer	2.96e-06	4.84e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.94e-06	4.81e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTEN—pancreatic cancer	2.87e-06	4.7e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.71e-06	4.43e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.68e-06	4.39e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.67e-06	4.37e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.65e-06	4.34e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.63e-06	4.3e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.58e-06	4.22e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	2.54e-06	4.15e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.35e-06	3.84e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.33e-06	3.8e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTEN—pancreatic cancer	2.29e-06	3.75e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.08e-06	3.4e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—pancreatic cancer	2.07e-06	3.39e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.05e-06	3.35e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.03e-06	3.32e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.03e-06	3.31e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.91e-06	3.12e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.9e-06	3.11e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.89e-06	3.1e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.77e-06	2.89e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.7e-06	2.77e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—pancreatic cancer	1.66e-06	2.71e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.62e-06	2.65e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.56e-06	2.55e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.55e-06	2.53e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.32e-06	2.16e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.25e-06	2.04e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.02e-06	1.67e-05	CbGpPWpGaD
